AQST · Aquestive Therapeutics, Inc. · Documents
$4.05
+0.22 (+5.74%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$512.80M
Shares
125.51M
Volume · Oct 20
2.26M
Avg daily vol (3M)
2.77M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-12-02 | — | |
| 8-K | — | 2024-11-07 | 2024-11-01 | |
| 8-K | — | 2024-11-06 | — | |
| 10-Q | — | 2024-11-04 | 2024-09-30 | |
| 8-K | — | 2024-11-04 | — | |
| 8-K | — | 2024-10-25 | — | |
| 8-K | — | 2024-10-24 | — | |
| 8-K | — | 2024-10-16 | — | |
| 8-K | — | 2024-09-27 | — | |
| 8-K | — | 2024-09-09 | — | |
| 8-K | — | 2024-08-14 | — | |
| 8-K | — | 2024-08-06 | — | |
| 10-Q | — | 2024-08-06 | 2024-06-30 | |
| 8-K | — | 2024-07-25 | — | |
| 8-K | — | 2024-06-21 | 2024-06-20 | |
| 8-K | — | 2024-06-07 | 2024-06-06 | |
| 8-K | — | 2024-06-06 | 2024-06-03 | |
| 8-K | — | 2024-05-08 | 2024-05-07 | |
| 8-K | — | 2024-05-07 | — | |
| 10-Q | — | 2024-05-07 | 2024-03-31 | |
| 8-K | — | 2024-04-29 | 2024-04-26 | |
| DEF 14A | — | 2024-04-26 | 2024-06-20 | |
| ARS | — | 2024-04-26 | 2023-12-31 | |
| DEFA14A | — | 2024-04-26 | — | |
| 8-K | — | 2024-04-22 | — | |
| S-3 | — | 2024-04-03 | — | |
| 8-K | — | 2024-04-01 | — | |
| 8-K | — | 2024-03-21 | 2024-03-19 | |
| 8-K | — | 2024-03-15 | 2024-03-14 | |
| 10-K | — | 2024-03-05 | 2023-12-31 | |
| 8-K | — | 2024-03-05 | — | |
| 8-K | — | 2023-12-08 | 2023-12-07 | |
| 8-K | — | 2023-12-05 | — | |
| 8-K | — | 2023-11-08 | — | |
| 8-K | — | 2023-11-06 | — | |
| 10-Q | — | 2023-11-06 | 2023-09-30 | |
| 8-K | — | 2023-11-02 | 2023-11-01 | |
| 8-K | — | 2023-10-10 | 2023-10-09 | |
| S-3 | — | 2023-09-21 | — | |
| 8-K | — | 2023-09-20 | — | |
| 8-K | — | 2023-08-11 | — | |
| 8-K | — | 2023-08-07 | — | |
| 10-Q | — | 2023-08-07 | 2023-06-30 | |
| 8-K | — | 2023-08-02 | 2023-08-01 | |
| 8-K | — | 2023-07-27 | — | |
| 8-K | — | 2023-06-29 | — | |
| 8-K | — | 2023-06-23 | — | |
| 8-K | — | 2023-05-31 | — | |
| ARS | — | 2023-05-02 | 2022-12-31 | |
| 8-K | — | 2023-05-02 | — |
Showing 51–100 of 213 filings
Key facts
CIK
1398733
CUSIP
03843E104
13F (30d)
15 filings
15 filers
Visit website
Investor relations